Fusion Antibodies Share Discussion Threads

[fhasson] 03/5/2018 21:45

Any update on the investors meeting on Wednesday Timbo?

[walbrook2] 25/4/2018 11:32

This is a post from Walbrook PR, we provide financial PR & IR services for Fusion Antibodies. As a reminder we are organising an investor event for the Company, details below. If you would like to attend please email Walbrook PR on - [e-mail] - rather than replying to this post. Thank you.

Fusion Antibodies will be hosting an investor presentation on Wednesday 2 May 2018. The briefing by Paul Kerr, CEO of Fusion will take place at Copper Bar, Balls Brothers, 6 Adams Court, Old Broad Street, EC2N 1DX from 4.30pm for a 4.45pm start and will be followed by drinks and networking.

If you would like to register to attend, please contact Walbrook PR on 020 7933 8780 or email [e-mail].

[fhasson] 23/4/2018 16:23

Unfortunately cannot make it but keep us informed. Hopefully some good news awaits us!

[timbo003] 23/4/2018 11:31

I received this E mail from Walbrook this morning, I shall definitely go along


Fusion Antibodies (AIM: FAB), a contract research organization providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications, announces that it will hold a presentation for investors on Wednesday, 2 May 2018.

The briefing by Paul Kerr, CEO of Fusion will take place at Copper Bar, Balls Brothers, 6 Adams Court, Old Broad Street, EC2N 1DX from 4.30pm for a 4.45pm start and will be followed by drinks and networking. If you would like to register to attend, please reply to: [e-mail]

[wetdream] 10/4/2018 17:59

Dealers trying to attract business.
Otherwise zzzzzz

[fhasson] 28/3/2018 17:16

Anyone know why price goes down on buys and no sells???

[fhasson] 26/3/2018 19:47

Very little but that will change.

[wetdream] 26/3/2018 17:35

No interest in this co. Is there?

[fhasson] 05/3/2018 22:24

Held well considering a profit warning

[wetdream] 05/3/2018 09:27

Probably came to market a bit too soon.

[fhasson] 05/3/2018 07:45

Agree it is a bit lame but they are still getting grounded in the process

[fhasson] 05/3/2018 07:33

Keen to top up but my initial buy price was 166p so looking for near 100p to bring down by average then sit tight for 3-5 years

[fhasson] 05/3/2018 07:28

Still recruiting new staff, affiliated with QUB with strong team of management and scientists, hot area of medicine to be in right now, new partners/ collaborations will start to emerge,new products in pipeline, building coming on well, growth on the up. I give this company a cautious thumbs up for now

[opodio] 05/3/2018 07:19

The next statement will say they were distracted by one off build and missed forecasts

new company cant afford disapoint on day one to 100

[fhasson] 05/3/2018 07:18

Profit warning might be too much but with increased capacity ahead of schedule and strong growth on the cards expect a few buying opportunities before this starts to get traction

[fhasson] 12/1/2018 14:26

MM could drop this to £1

[bamboo2] 12/1/2018 09:47

Price now just above prior common gap. Would prefer to see the gap filled.
potential turn date 22 January.

[bamboo2] 07/1/2018 21:04

luci, I would also be interested to see your evidence.

[fhasson] 07/1/2018 20:50

Is there going to be a dilution of share price? Where are you getting this information from? Would appreciate your input.Thanks

[fhasson] 07/1/2018 20:43

What's going to 50p?